1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of NPY1R mRNA CTD PMID:28189721 , PMID:28960355 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of NPY1R mRNA CTD PMID:17555576 17beta-estradiol multiple interactions ISO RGD:1347163 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of NPY1R mRNA more ... CTD PMID:19146866 more ... 17beta-estradiol multiple interactions ISO RGD:3198 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of NPY1R mRNA CTD PMID:26496021 17beta-estradiol increases expression ISO RGD:1347163 6480464 Estradiol results in increased expression of NPY1R mRNA CTD PMID:19146866 more ... 1D-myo-inositol 1,4,5-trisphosphate affects abundance ISO RGD:3198 6480464 NPY1R protein affects the abundance of Inositol 1 more ... CTD PMID:7742479 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1347163 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of NPY1R mRNA, Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of NPY1R mRNA] CTD PMID:11007951 , PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1347163 6480464 Tetrachlorodibenzodioxin results in decreased expression of NPY1R mRNA CTD PMID:11007951 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NPY1R mRNA CTD PMID:19933214 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:3198 6480464 Trinitrobenzenesulfonic Acid results in increased expression of NPY1R mRNA CTD PMID:23537331 2-methyl-4-chlorophenoxybutyric acid multiple interactions ISO RGD:3198 6480464 [2-amino-3-chloro-1, 4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in increased expression of NPY1R mRNA CTD PMID:29321614 6-propyl-2-thiouracil increases expression ISO RGD:3198 6480464 Propylthiouracil results in increased expression of NPY1R mRNA CTD PMID:24780913 afimoxifene multiple interactions ISO RGD:1347163 6480464 afimoxifene inhibits the reaction [Estrogens results in increased expression of NPY1R mRNA] CTD PMID:21233418 aflatoxin B1 affects expression ISO RGD:1347163 6480464 Aflatoxin B1 affects the expression of NPY1R protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1347163 6480464 Aflatoxin B1 results in decreased methylation of NPY1R gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:3198 6480464 Aflatoxin B1 results in increased expression of NPY1R mRNA CTD PMID:23630614 all-trans-retinoic acid increases expression ISO RGD:1347163 6480464 Tretinoin results in increased expression of NPY1R mRNA CTD PMID:21934132 all-trans-retinol increases response to substance EXP 6480464 NPY1R protein results in increased susceptibility to Vitamin A CTD PMID:17400914 ammonium chloride affects expression ISO RGD:3198 6480464 Ammonium Chloride affects the expression of NPY1R mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:1347163 6480464 Antirheumatic Agents results in increased expression of NPY1R mRNA CTD PMID:24449571 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of NPY1R mRNA CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:1347163 6480464 Benzoapyrene results in increased expression of NPY1R mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:1347163 6480464 Benzoapyrene results in increased methylation of NPY1R 5' UTR, Benzoapyrene results in increased methylation of NPY1R promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions EXP 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of NPY1R mRNA CTD PMID:27858113 benzo[b]fluoranthene increases expression EXP 6480464 benzobfluoranthene results in increased expression of NPY1R mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions EXP 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of NPY1R mRNA CTD PMID:27858113 bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of NPY1R mRNA CTD PMID:15674844 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1347163 6480464 Diethylhexyl Phthalate results in decreased expression of NPY1R mRNA CTD PMID:31163220 bisphenol A multiple interactions ISO RGD:3198 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of NPY1R mRNA, [bisphenol A co-treated with Genistein] results in increased methylation of NPY1R gene CTD PMID:26496021 , PMID:28505145 bisphenol A decreases expression ISO RGD:1347163 6480464 bisphenol A results in decreased expression of NPY1R mRNA CTD PMID:27685785 bisphenol A decreases expression ISO RGD:3198 6480464 bisphenol A results in decreased expression of NPY1R mRNA CTD PMID:25181051 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of NPY1R mRNA CTD PMID:30951980 cadmium atom multiple interactions EXP 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of NPY1R mRNA CTD PMID:31904401 cadmium dichloride decreases methylation ISO RGD:3198 6480464 Cadmium Chloride results in decreased methylation of NPY1R promoter CTD PMID:22457795 cadmium dichloride multiple interactions EXP 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of NPY1R mRNA CTD PMID:31904401 capsaicin multiple interactions ISO RGD:3198 6480464 neuropeptide Y, Leu31-Pro34- inhibits the reaction [NPY1R protein results in increased susceptibility to Capsaicin] CTD PMID:16714086 capsaicin increases response to substance ISO RGD:3198 6480464 NPY1R protein results in increased susceptibility to Capsaicin CTD PMID:16714086 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 chrysene multiple interactions EXP 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of NPY1R mRNA CTD PMID:27858113 coumestrol multiple interactions ISO RGD:1347163 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:18310284 , PMID:19167446 coumestrol increases expression ISO RGD:1347163 6480464 Coumestrol results in increased expression of NPY1R mRNA CTD PMID:19167446 cycloheximide multiple interactions ISO RGD:1347163 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of NPY1R mRNA] CTD PMID:11007951 cyclosporin A decreases expression ISO RGD:1347163 6480464 Cyclosporine results in decreased expression of NPY1R mRNA CTD PMID:20106945 cyromazine multiple interactions ISO RGD:3198 6480464 [2-amino-3-chloro-1, 4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in increased expression of NPY1R mRNA CTD PMID:29321614 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of NPY1R mRNA CTD PMID:22733784 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NPY1R mRNA CTD PMID:29950665 dibenz[a,h]anthracene increases expression EXP 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression ISO RGD:3198 6480464 Dibutyl Phthalate results in increased expression of NPY1R mRNA CTD PMID:15620428 dioxygen increases expression ISO RGD:1347163 6480464 Oxygen deficiency results in increased expression of NPY1R mRNA CTD PMID:25596134 dorsomorphin multiple interactions ISO RGD:1347163 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 Enterolactone multiple interactions ISO RGD:1347163 6480464 [Coumestrol co-treated with 2, 3-bis3'-hydroxybenzylbutyrolactone] results in increased expression of NPY1R mRNA CTD PMID:19167446 fluoxetine affects expression ISO RGD:3198 6480464 Fluoxetine affects the expression of NPY1R mRNA CTD PMID:9729278 genistein multiple interactions ISO RGD:3198 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of NPY1R gene CTD PMID:28505145 genistein increases expression EXP 6480464 Genistein results in increased expression of NPY1R mRNA CTD PMID:32186404 ifosfamide increases expression ISO RGD:1347163 6480464 Ifosfamide results in increased expression of NPY1R mRNA CTD PMID:25596134 ketamine decreases expression ISO RGD:3198 6480464 Ketamine results in decreased expression of NPY1R mRNA CTD PMID:20080153 lead diacetate increases expression ISO RGD:3198 6480464 lead acetate results in increased expression of NPY1R mRNA CTD PMID:11578147 medroxyprogesterone acetate multiple interactions ISO RGD:1347163 6480464 Medroxyprogesterone Acetate inhibits the reaction [Estradiol results in increased expression of NPY1R mRNA] CTD PMID:19146866 medroxyprogesterone acetate decreases expression ISO RGD:1347163 6480464 Medroxyprogesterone Acetate results in decreased expression of NPY1R mRNA CTD PMID:18497975 mercury dichloride increases expression ISO RGD:3198 6480464 Mercuric Chloride results in increased expression of NPY1R mRNA CTD PMID:16507785 methamphetamine increases response to substance ISO RGD:1347163 6480464 NPY1R gene SNP results in increased susceptibility to Methamphetamine CTD PMID:19566775 methamphetamine affects expression EXP 6480464 Methamphetamine affects the expression of NPY1R mRNA CTD PMID:15930374 methylmercury chloride decreases expression ISO RGD:1347163 6480464 methylmercuric chloride results in decreased expression of NPY1R mRNA CTD PMID:28001369 morphine decreases expression EXP 6480464 Morphine results in decreased expression of NPY1R mRNA CTD PMID:20144693 N-Nitrosopyrrolidine increases expression ISO RGD:1347163 6480464 N-Nitrosopyrrolidine results in increased expression of NPY1R mRNA CTD PMID:32234424 nickel atom decreases expression ISO RGD:1347163 6480464 Nickel results in decreased expression of NPY1R mRNA CTD PMID:24768652 , PMID:25583101 O-methyleugenol increases expression ISO RGD:1347163 6480464 methyleugenol results in increased expression of NPY1R mRNA CTD PMID:32234424 panobinostat multiple interactions ISO RGD:1347163 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of NPY1R mRNA CTD PMID:27188386 panobinostat decreases expression ISO RGD:1347163 6480464 panobinostat results in decreased expression of NPY1R mRNA CTD PMID:26272509 pentobarbital multiple interactions EXP 6480464 NPY1R protein affects the reaction [NPY protein results in increased susceptibility to Pentobarbital] CTD PMID:11454027 pentobarbital increases response to substance EXP 6480464 NPY1R protein results in increased susceptibility to Pentobarbital CTD PMID:11454027 phenylmercury acetate decreases expression ISO RGD:1347163 6480464 Phenylmercuric Acetate results in decreased expression of NPY1R mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1347163 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of NPY1R mRNA CTD PMID:27188386 phenylpropanolamine affects response to substance ISO RGD:3198 6480464 NPY1R protein affects the susceptibility to Phenylpropanolamine CTD PMID:23052195 phenylpropanolamine multiple interactions ISO RGD:3198 6480464 NPY1R protein affects the reaction [Phenylpropanolamine results in decreased expression of NPY protein] CTD PMID:23052195 phenylpropanolamine increases expression ISO RGD:3198 6480464 Phenylpropanolamine results in increased expression of NPY1R protein CTD PMID:23052195 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of NPY1R mRNA CTD PMID:31904401 picrotoxin increases expression ISO RGD:3198 6480464 Picrotoxin results in increased expression of NPY1R mRNA CTD PMID:15170462 pioglitazone multiple interactions EXP 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of NPY1R mRNA CTD PMID:27935865 pirimicarb multiple interactions ISO RGD:3198 6480464 [2-amino-3-chloro-1, 4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in increased expression of NPY1R mRNA CTD PMID:29321614 progesterone increases expression ISO RGD:1347163 6480464 Progesterone results in increased expression of NPY1R mRNA CTD PMID:18070364 raloxifene multiple interactions ISO RGD:1347163 6480464 Raloxifene Hydrochloride inhibits the reaction [Estradiol results in increased expression of NPY1R mRNA] CTD PMID:21185374 resveratrol multiple interactions ISO RGD:1347163 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of NPY1R mRNA CTD PMID:19167446 SB 431542 multiple interactions ISO RGD:1347163 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1347163 6480464 Silicon Dioxide analog results in decreased expression of NPY1R mRNA CTD PMID:25895662 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of NPY1R mRNA CTD PMID:17555576 tetrachloromethane affects expression ISO RGD:3198 6480464 Carbon Tetrachloride affects the expression of NPY1R mRNA CTD PMID:12734012 tetraphene multiple interactions EXP 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of NPY1R mRNA CTD PMID:27858113 thiram multiple interactions ISO RGD:3198 6480464 [2-amino-3-chloro-1, 4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in increased expression of NPY1R mRNA CTD PMID:29321614 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NPY1R mRNA CTD PMID:29950665 tribromoethanol increases response to substance EXP 6480464 NPY1R protein results in increased susceptibility to tribromoethanol CTD PMID:11454027 trichostatin A increases expression ISO RGD:1347163 6480464 trichostatin A results in increased expression of NPY1R mRNA CTD PMID:24935251 trichostatin A decreases expression ISO RGD:1347163 6480464 trichostatin A results in decreased expression of NPY1R mRNA CTD PMID:24935251 trifluoroacetic acid multiple interactions ISO RGD:3198 6480464 Trifluoroacetic Acid binds to and results in decreased activity of NPY1R protein CTD PMID:16714086 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of NPY1R mRNA CTD PMID:19136453 valproic acid multiple interactions ISO RGD:1347163 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of NPY1R mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1347163 6480464 Valproic Acid results in increased expression of NPY1R mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1347163 6480464 Valproic Acid affects the expression of NPY1R mRNA CTD PMID:25979313 ziram multiple interactions ISO RGD:3198 6480464 [2-amino-3-chloro-1, 4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in increased expression of NPY1R mRNA CTD PMID:29321614
